May 1, 2024

Salk immunologist Susan Kaech elected to National Academy of Sciences

索尔克新闻


Salk immunologist Susan Kaech elected to National Academy of Sciences

LA JOLLA—Salk Institute Professor 苏珊·凯奇 has been elected to the U.S. National Academy of Sciences. Kaech is one of 120 new members and 24 international members to be elected to the academy in recognition of their distinguished and continuing achievements in original research. The election is considered one of the highest honors accorded to a scientist in the United States. Kaech’s work has transformed the fields of immunology and cancer biology and inspires new approaches to cancer immunotherapy. Her recognition brings the number of Salk faculty elected to the National Academy of Sciences to 13.

“Sue’s work continues to shape the way we understand and treat viral infection, chronic disease, and cancer,” says Salk Institute President 杰拉尔德·乔伊斯. “We are inspired by her considerable influence on the field of immunobiology and thrilled to see her recognized by the prestigious National Academy of Sciences.”

Susan Kaech
苏珊·凯奇
点击此处 用于高分辨率图像。.
版权:萨克研究所

Kaech is director of the NOMIS Center for Immunobiology and Microbial Pathogenesis and holder of the NOMIS Chair at Salk. Her discoveries have contributed significantly to the modern understanding of long-term immunity and how memory T cells form. Memory T cells are critical for maintaining long-term immunity during acute and chronic infections, and can also be suppressed in cancer. Kaech identified several genes and signaling molecules that are critical for memory T cell generation during immune responses. She also helped establish the field of cancer immunometabolism through her characterization of the metabolic interplay between tumors and immune cells, and how changes in nutrient availability can lead to metabolic immune suppression in tumors.

Kaech’s lab recently moved into a new direction by finding that T cells listen to neurotransmitters released by neighboring neurons in tissues, regulating their anti-viral and anti-tumor functions. Working with long-time collaborator Salk Professor 杰拉尔德·沙德尔 and team, Kaech’s lab recently discovered that rewiring the flow of electrons in tumor mitochondria can enhance the immune system’s ability to recognize and fight cancer.

Kaech is also a member of the American Academy of Arts and Sciences and a Fellow of the American Association for the Advancement of Science. She has received numerous awards including a Howard Hughes Medical Institute Early Career Scientist award, the National Institutes of Health Presidential Early Career Award for Scientists and Engineers, the Burroughs Wellcome Fund Career Award in the Biosciences, and the Damon Runyon-Walter Winchell Cancer Research Fellowship, among others. She was also recently elected to the American Association of Immunologists Council, which serves as the largest and most influential organization to advance the knowledge of immunology and medical research in the country.

The National Academy of Sciences is a private, nonprofit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863. It recognizes achievement in science by election to membership, and—with the National Academy of Engineering and the National Academy of Medicine—provides science, engineering, and health policy advice to the federal government and other organizations.

研究领域

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.